Reuters – Pfizer Inc agreed on Wednesday to plead guilty to a U.S. criminal charge relating to promotion of its now-withdrawn Bextra pain medicine and will pay a record $2.3 billion to settle allegations it improperly marketed 13 medicines.
Tags: Allegations, Bextra, Medicine, Medicines, Pain Medicine, Pfizer, Pfizer Inc, Plea, Reuters